Growth factors and scaffold composition influence properties of tissue engineered human septal cartilage implants in a murine model

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 4, 2008, Pages 807-816

  Skodacek, D ^a   Brandau, S ^b   Deutschle, T ^c   Lang, S ^b   Rotter, Nicole ^c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Cartilage; Growth factors; Nasal chondrocytes; Tissue engineering

Indexed keywords

COPOLYMER; GLYCOSAMINOGLYCAN; HYDROXYPROLINE; POLYDIOXANONE; POLYGLYCOLIC ACID; POLYLACTIC ACID; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CARTILAGE CELL; CARTILAGE TRANSPLANTATION; CELL CULTURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NOSE CARTILAGE; NOSE SEPTUM; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE ENGINEERING;

EID: 59849097812     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100405     Document Type: Article

References (30)

1. Verwoerd-Verhoef HL, ten Koppel PG, van Osch GJ, Meeuwis CA, Verwoerd CD. Wound healing of cartilage structures in the head and neck region. Int J Pediatr Otorhinolaryngol 1998; 43:241-51.
2. Ohara K, Nakamura K, Ohta E. Chest wall deformities and thoracic scoliosis after costal cartilage graft harvesting. Plast Reconstr Surg 1994; 93:1030-36.
3. Freed LE, Langer R, Martin I, Pellis NR, Vunjak-Novakovic G. Tissue engineering of cartilage in space. Proc Natl Acad Sci USA 1997; 94:13885-90.
4. Freed LE, Vunjak-Novakovic G, Biron RJ, Eagles DB, Lesnoy DC, Barlow SK, et al. Biodegradable polymer scaffolds for tissue engineering. Biotechnology (NY) 1994; 12:689-93.
5. Rotter N, Ung F, Roy AK, Vacanti M, Eavey RD, Vacanti CA, et al. Role for interleukin 1alpha in the inhibition of chondrogenesis in autologous implants using polyglycolic acid-polylactic acid scaffolds. Tissue Eng 2005; 11:192-200.
6. Vacanti CA, Langer R, Schloo B, Vacanti JP. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg 1991; 88:753-59.
7. Trippel SB. Growth factor actions on articular cartilage. J Rheumatol Suppl 1995; 43:129-32.
8. Majumdar MK, Banks V, Peluso DP, Morris EA. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal. cells. J Cell Physiol 2000; 185:98-106.
9. Morales TI. Transforming growth factor-beta 1 stimulates synthesis of proteoglycan aggregates in calf articular cartilage organ cultures. Arch Biochem Biophys 1991; 286:99-106.
10. van Susante JL, Buma P, van Beuningen HM, van den Berg WB, Veth RP. Responsiveness of bovine chondrocytes to growth factors in medium with different serum concentrations. J Orthop Res 2000; 18:68-77.
11. Van Osch GJ, Van Der Veen SW, Burger EH, Verwoerd-Verhoef HL. Chondrogenic potential of in vitro multiplied rabbit perichondrium cells cultured in alginate beads in defined medium. Tissue Eng 2000; 6:321-30.
12. van Osch GJ, van den Berg WB, Hunziker EB, Hauselmann HJ. Differential effects of IGF-1 and TGF beta-2 on the assembly of proteoglycans in pericellular and territorial matrix by cultured bovine articular chondrocytes. Osteoarthritis Cartilage 1998; 6:187-95.
13. Kim YJ, Sah RL, Doong JY, Grodzinsky AJ. Fluorometric assay of DNA in cartilage explants using hoechst 33258. Analytical Biochemistry 1988; 174:168-76.
14. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986; 883:173-77.
15. Stegemann H, Stalder K. Determination of hydroxyproline. Clin Chim Acta 1967; 18:267-73.
16. Yaeger PC, Masi TL, de Ortiz JL, Binette F, Tubo R, McPherson JM. Synergistic action of transforming growth factor-beta and insulin-like growth factor-I induces expression of type II collagen and aggrecan genes in adult human articular chondrocytes. Exp Cell Res 1997; 237:318-25.
17. Jenniskens YM, Koevoet W, de Bart AC, Weinans H, Jahr H, Verhaar JA, et al. Biochemical and functional modulation of the cartilage collagen network by IGF1, TGFbeta2 and FGF2. Osteoarthritis Cartilage 2006; 14:1136-46.
18. de Haart M, Marijnissen WJ, van Osch GJ, Verhaar JA. Optimization of chondrocyte expansion in culture. Effect of TGF beta-2, bFGF and L-ascorbic acid on bovine articular chondrocytes. Acta Orthop Scand 1999; 70:55-61.
19. Froger-Gaillard B, Hossenlopp P, Adolphe M, Binoux M. Production of insulin-like growth factors and their binding proteins by rabbit articular chondrocytes: relationships with cell multiplication. Endocrinology 1989; 124:2365-72.
20. Jakob M, Demarteau O, Schafer D, Hintermann B, Dick W, Heberer M, et al. Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J Cell Biochem 2001; 81:368-77.
21. Malemud CJ, Killeen W, Hering TM, Purchio AF. Enhanced sulfated-proteoglycan core protein synthesis by incubation of rabbit chondrocytes with recombinant transforming growth factor-beta l. J Cell Physiol 1991; 149:152-59.
22. Pei M, Seidel J, Vunjak-Novakovic G, Freed LE. Growth factors for sequential cellular de- and re-differentiation in tissue engineering. Biochem Biophys Res Commun 2002; 294:149-54.
23. Redini F, Galera P, Mauviel A, Loyau G, Pujol JP. Transforming growth factor beta stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes. FEBS Lett 1988; 234: 172-76.
24. van Osch GJ, Marijnissen WJ, van der Veen SW, Verwoerd-Verhoef HL. The potency of culture-expanded nasal septum chondrocytes for tissue engineering of cartilage. Am J Rhinol 2001 15: 187-92.
25. Vunjak-Novakovic G, Obradovic B, Martin I, Bursae PM, Langer R, Freed LE. Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. Biotechnol Prog 1998; 14:193-202.
26. Lavezzi A, Mantovani M, delta Berta LG, Matturri L. Cell kinetics of human nasal septal chondrocytes in vitro: importance for cartilage grafting in otolaryngology. J Otolaryngol 2002; 31:366-70.
27. Alexander TH, Sage AB, Schumacher BL, Sah RL, Watson D. Human serum for tissue engineering of human nasal septal cartilage. Otolaryngol Head Neck Surg 2006; 135:397-403.
28. Yamaga KM, Bolen H, Kimura L, Lance EM. Enhanced chondrocyte destruction by lymphokine-activated killer cells. Possible role in rheumatoid arthritis. Arthritis Rheum 1993; 36:500-13.
29. Marijnissen WJ, van Osch GJ, Aigner J, van der Veen SW, Hollander AP, Verwoerd-Verhoef HL, et al. Alginate as a chondrocyte-delivery substance in combination with a non-woven scaffold for cartilage tissue engineering. Biomaterials 2002; 23:1511-7.
30. Marijnissen WJ, van Osch GJ, Aigner J, Verwoerd-Verhoef HL, Verhaar JA. Tissue-engineered cartilage using serially passaged articular chondrocytes. Chondrocytes in alginate, combined in vivo with a synthetic (E210) or biologic biodegradable carrier (DBM). Biomaterials 2000; 21:571-80.